{"schema_version":"1","generated_at":"2026-11-15T12:11:17.343Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/evan-stein","json_url":"https://www.findmykol.com/kol/evan-stein/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"evan-stein","name":"Evan Stein","credential":"MD","specialty":"Cardiovascular Disease","specialty_raw":"Cardiovascular Disease","therapeutic_area":"Cardiology","therapeutic_areas":["Cardiology"],"city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1922142223"},"summary":"Evan Stein is a Dyslipidemia / Lipid Disorders physician. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.","overview":{"text":"Evan Stein, MD, is profiled from the public federal record. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 1 companies.","bullets":["Top research focus: Dyslipidemia / Lipid Disorders","10 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-11-14"},"focus":{"indications":[{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":7,"topics":0,"strength":21},{"label":"Cardiovascular Diseases","therapeutic_area":"Cardiology","trials":3,"topics":0,"strength":9},{"label":"Vascular Diseases","therapeutic_area":"Cardiology","trials":3,"topics":0,"strength":9},{"label":"Homozygous Familial Hypercholesterolemia","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Hypertriglyceridemia","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Myocardial Infarction","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Stroke","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3}],"research_topics":["Dyslipidemia / Lipid Disorders","Cardiovascular Diseases","Vascular Diseases","Myocardial Infarction"],"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"LIB Therapeutics LLC","trials":7,"payments":0,"mentions":7},{"name":"Alkermes, Inc.","trials":0,"payments":4,"mentions":4},{"name":"AstraZeneca","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05004675","title":"Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients","phase":"PHASE3","status":"COMPLETED","role":"Investigator","sponsor":"LIB Therapeutics LLC","source_url":"https://clinicaltrials.gov/study/NCT05004675","trial_url":"https://www.findmykol.com/trial/NCT05004675"},{"nct":"NCT04806893","title":"Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction","phase":"PHASE3","status":"UNKNOWN","role":"Investigator","sponsor":"LIB Therapeutics LLC","source_url":"https://clinicaltrials.gov/study/NCT04806893","trial_url":"https://www.findmykol.com/trial/NCT04806893"},{"nct":"NCT04797247","title":"Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction","phase":"PHASE3","status":"UNKNOWN","role":"Investigator","sponsor":"LIB Therapeutics LLC","source_url":"https://clinicaltrials.gov/study/NCT04797247","trial_url":"https://www.findmykol.com/trial/NCT04797247"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":2021},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Alkermes, Inc.","program_year":2021,"amount_usd":82500,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922142223"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1922142223","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cardiovascular","share_pct":100,"classes_total":3,"classes":[{"class":"PCSK9 Inhibitor","setting":"prescribed","share_pct":46.3,"drugs":[{"name":"Repatha Sureclick","share_pct":100}],"max_beneficiaries":null},{"class":"Cholesterol absorption inhibitor","setting":"prescribed","share_pct":29.6,"drugs":[{"name":"Ezetimibe","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":0,"rows_total":9,"shown":3,"withheld":6,"rows":[{"project":"M01RR000068","title":"LONG-TERM PLASMA EXCHANGE IN FAMILIAL HYPERCHOLESTEROLEMIA","fiscal_year":1990,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/M01RR000068"},{"project":"R01HL028356","title":"LONG-TERM PLASMA EXCHANGE IN FAMILIAL HYPERCHOLESTEROLEM","fiscal_year":1987,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/R01HL028356"},{"project":"R01HL028356","title":"LONG-TERM PLASMA EXCHANGE IN FAMILIAL HYPERCHOLESTEROLEM","fiscal_year":1986,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/R01HL028356"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"presence":{"mentions":{"total":2,"shown":2,"rows":[{"url":"https://www.cardiometabolichealth.org/faculty/evan-stein/","platform":"other","status":"provisional"},{"url":"https://www.hcplive.com/view/lerodalcibep-efficaciously-reduces-ldl-c-lastingly-and-long-term-with-evan-stein-md-phd","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"similar":[{"name":"Deepak Bhatt","slug":"deepak-bhatt","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/deepak-bhatt","json_url":"https://www.findmykol.com/kol/deepak-bhatt/profile.json"},{"name":"Harlan Krumholz","slug":"harlan-krumholz","institution":"Yale School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/harlan-krumholz","json_url":"https://www.findmykol.com/kol/harlan-krumholz/profile.json"},{"name":"Martin Leon","slug":"martin-leon","institution":"Columbia University Irving Medical Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/martin-leon","json_url":"https://www.findmykol.com/kol/martin-leon/profile.json"},{"name":"Gregg Fonarow","slug":"gregg-fonarow","institution":"Ronald Reagan UCLA Medical Center","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/gregg-fonarow","json_url":"https://www.findmykol.com/kol/gregg-fonarow/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7,"funding":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-13"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2021","collected_at":"2026-11-13"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}